The present invention is directed to novel 1,2,4-thiadiazole derivatives useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders such as obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, spinal cord injury, nerve injury, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibomian gland disorder, pseudofolliculitis, yeast infections, dandruff, hidradenitis suppurativa, ocular rosacea and eccrine gland disorder.

 
Web www.patentalert.com

< Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor

< Amidoheterocycles as modulators of the melanocortin-4 receptor

> 3-azabicyclo[3.1.0]hexane derivatives

> N-benzoylureidocinnamic acid derivatives, processes for preparing them and their use

~ 00264